Table I.
Significant pathways.
| KEGG ID | Term | Count | P-value |
|---|---|---|---|
| 04512 | ECM-receptor interaction | 25 | 1.99E-07 |
| 04510 | Focal adhesion | 43 | 3.87E-07 |
| 05200 | Pathways in cancer | 55 | 2.95E-05 |
| 05144 | Malaria | 13 | 5.66E-04 |
| 03320 | PPAR signaling pathway | 16 | 7.59E-04 |
| 04110 | Cell cycle | 23 | 1.69E-03 |
| 04115 | p53 signaling pathway | 14 | 5.14E-03 |
| 05222 | Small cell lung cancer | 16 | 8.33E-03 |
| 05218 | Melanoma | 14 | 8.75E-03 |
| 00565 | Ether lipid metabolism | 8 | 8.89E-03 |
| 04530 | Tight junction | 22 | 8.95E-03 |
| 04270 | Vascular smooth muscle contraction | 19 | 9.89E-03 |
| 04114 | Oocyte meiosis | 19 | 9.89E-03 |
| 04520 | Adherens junction | 14 | 9.91E-03 |
| 04350 | TGF-β signaling pathway | 15 | 1.21E-02 |
| 05215 | Prostate cancer | 16 | 1.29E-02 |
| 04610 | Complement and coagulation cascades | 13 | 1.29E-02 |
| 04710 | Circadian rhythm - mammal | 6 | 1.37E-02 |
| 04914 | Progesterone-mediated oocyte maturation | 15 | 1.67E-02 |
| 04614 | Renin-angiotensin system | 5 | 2.12E-02 |
| 00982 | Drug metabolism - cytochrome P450 | 11 | 2.81E-02 |
| 00564 | Glycerophospholipid metabolism | 13 | 3.12E-02 |
| 04916 | Melanogenesis | 16 | 3.29E-02 |
| 05219 | Bladder cancer | 8 | 4.49E-02 |
| 05221 | Acute myeloid leukemia | 10 | 4.60E-02 |
| 04360 | Axon guidance | 19 | 4.65E-02 |
KEGG, Kyoto Encyclopedia of Genes and Genomes; ECM, extracellular matrix; PPAR, peroxisome proliferator-activated receptor; TGF, transforming growth factor.